Frédéric Rieux-Laucat

Immunogenetics of pediatric autoimmune diseases

Publish at

Presentation

Frédéric Rieux-Laucat

Contact

Send a message

Immunogenetics of pediatric autoimmune diseases

This project focuses on the mechanisms involved in the control of self-tolerance in primary human immunodeficiencies and in hyper immune syndromes. The autoimmune lymphoproliferative syndrome (ALPS) is associated with mutations of the Fas gene and apoptosis deficiencies. It is characterized by a benign tumoral syndrome along with autoimmune cytopenias.This condition thus represents a key model to study some aspects predisposing to autoimmune diseases in the context of apoptosis deficiency. Moreover, the genetic and clinical variability of the ALPS suggests that additional factors are involved in the onset of the disease.

The main goal of this work is to identify the modifiers involved in ALPS with Fas deficiency and to evaluate their possible contribution in similar or related conditions with yet undefined mechanisms. In addition of extrinsic and intrinsic apoptosis pathways study we analyze the development and the function of regulatory T cells in the context of ALPS. Such study is also performed in autoimmune disorders associated with deficiency of the regulatory T cells like in Immunodysregulation Polyendocrinopathy Enteropathy X-linked (IPEX) and in IPEX-like patients with autosomal inheritence, as well as in severe combined immunodeficiencies. This project is based on the availability of the patients’ blood samples, as well as on the development of animal or cellular models. This work should provide a better understanding of the molecular and cellular bases of the mechanisms involved in T cells homeostasis and self-tolerance, and should allow the identification of susceptibility factors to human auto-immune diseases.

 

To read also

  • Care

    22/04/2025

    Clarifying the role of IKKα kinase in the function of the NF-κB inflammation pathway

    A signaling pathway is a series of steps, initiated by a stimulus, involving several molecules within a biological cell. These pathways are crucial for coordinating the growth, regulation and function of cells and tissues. If signaling between or within cells is deregulated, inappropriate cellular responses can lead to cancer or other diseases such as autoimmune diseases or, conversely, immune deficiencies. The NF-κB signaling pathway is involved in our immune and inflammatory responses. It can be activated in two different ways: the canonical pathway (activated rapidly by numerous stimuli) and the non-canonical pathway (activated later by more restricted stimuli). Researchers from the “Immunogenetics of Pediatric Autoimmune Diseases” laboratory at Institut Imagine looked at a patient with hypogammaglobulinemia, recurrent lung infections and Hay-Wells syndrome, who carried two mutations in the CHUK gene (one on each allele) encoding the IKKα protein. Their results, recently published in the Journal of Experimental Medicine, showed that these two mutations in the CHUK gene altered activation of the non-canonical NF-κB pathway, but also to a lesser extent the canonical pathway, confirming a crucial role for IKKα in both pathways. These results clarify our understanding of the functioning of the NF-κB pathway, involved in numerous biological mechanisms such as intercellular communication, innate and adaptive immune response and inflammatory response. They also shed light on the role of IKKα in this signaling pathway. This gene is still little studied, as highly deleterious mutations in IKKα seem to drastically affect development. The identification of this new mutation therefore represents a breakthrough in the diagnosis of children with symptoms similar to those of the patient.

  • Cellule dendritique

    Research Acceleration

    21/10/2020

    SOCS1: a newcomer in autoimmune diseases

  • Institut Imagine

    Imagine Institute

    01/10/2019

    The 2018 annual report is online

Cellules du colon

Research: a scientific adventure

Our goal: to better understand genetic diseases to better treat them.